Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Court halts rule requiring drug list pricing in advertising

Key clinical point: Court blocks rule that would put drug list prices in television ads.

Major finding: Court states that the HHS lacks the authority to require manufacturers to state list prices in ads.

Study details: In its ruling, the court questioned why the HHS chose to issue the regulation though the CMS given that the agency and drug manufacturers have no direct interaction, even though pricing does have an impact on the operation of the public insurance programs.

Disclosures: None.


U.S. District Court for the District of Columbia ruling.